Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Cardiac failure+1

Recruiting

InvestigationalNo placebo

A study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction

InvestigationalNo placebo

Greece

Participants:0–17 years · 18–64 years
Substances:Finerenone

Contact Research Centre

Cardiac failure+1

Recruiting

Investigational

A study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function

Investigational

Greece

Participants:0–17 years
Substances:Finerenone

Contact Research Centre

Pulmonary hypertension

Recruiting

Investigational

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Pulmonary arterial hypertension

Recruiting

Investigational

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Investigational

Greece

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Ltp001

Contact Research Centre

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Recruiting

Investigational

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Finerenone

Contact Research Centre

Hypertrophic cardiomyopathy

Recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Aficamten

Contact Research Centre

Pulmonary arterial hypertension

Not yet recruiting

Investigational

A Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Pulmonary hypertension

Not yet recruiting

Investigational

Long‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Treprostinil Palmitil

Contact Research Centre

Hypertrophic cardiomyopathy

Not yet recruiting

Investigational

Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Mavacamten

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drugNo placebo

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Sotatercept

Contact Research Centre

Find therapies in clinical trials near you

22 trials match your criteria

Cardiac failure+1

A study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction

Cardiac failure+1

A study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function

Pulmonary hypertension

Testing Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease

Pulmonary arterial hypertension

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Study on the Effects and Safety of Finerenone for Patients with Heart Failure Who Cannot Use Steroidal Mineralocorticoid Receptor Antagonists

Hypertrophic cardiomyopathy

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

Pulmonary arterial hypertension

A Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension

Pulmonary hypertension

Long‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease

Hypertrophic cardiomyopathy

Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Atrial fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Pulmonary arterial hypertension

A Study of PF-07868489 Safety and Effectiveness in Adults with Pulmonary Arterial Hypertension Who Participated in a Previous PF-07868489 Trial

Pulmonary arterial hypertension

Long-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.